Form 8-K - Current report:
SEC Accession No. 0001854270-24-000094
Filing Date
2024-07-17
Accepted
2024-07-17 16:15:27
Documents
15
Period of Report
2024-07-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20240717.htm   iXBRL 8-K 38361
2 EX-3.1 a202407178kex31.htm EX-3.1 14813
3 EX-4.1 a202407178kex41.htm EX-4.1 21498
  Complete submission text file 0001854270-24-000094.txt   216477

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20240717.xsd EX-101.SCH 1904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20240717_lab.xml EX-101.LAB 23433
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20240717_pre.xml EX-101.PRE 13580
17 EXTRACTED XBRL INSTANCE DOCUMENT snti-20240717_htm.xml XML 2935
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 241122402
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)